Alzheimer's Disease

A brain plaque inhibitor developed by Merck is now being tested in larger studies for efficacy against the still unstoppable neurodegenerative disease

Metformin may slow or reverse dementia and cognitive impairment, even in nondiabetics 

Patients who received the antibody therapy had reduced levels of amyloid protein in their brains after one year

The costs for reminders to eat, shower or take medication can be staggering

Scientists search for the Marie Kondo of the brain—a drug to clear cellular debris

How a brief intervention could have such long-lasting results remains unclear

AI algorithms used with MRI brain scans help distinguish between patients with Alzheimer's and two early forms of dementia that can be precursors to the memory-robbing disease

Progressive supranuclear palsy has become a test bed for therapies aimed at the tau protein thought to be behind many devastating neurodegenerative disorders

A new study finds that a key protein implicated in Alzheimer’s may normally protect the brain from infection

Research on a key brain immune cell suggests it is a tantalizing but slippery target for new therapies 

A study in mice shows that the normal process by which the brain prunes excess synapses during development may be hijacked early on in the progression of Alzheimer’s and other neurodegenerative diseases

A new study in rats could one day benefit people suffering neurological conditions associated with the buildup of unwanted proteins in the brain, including traumatic brain injury and Alzheimer’s